BR9809745A - Sal cristalino de amina de cefdinir - Google Patents

Sal cristalino de amina de cefdinir

Info

Publication number
BR9809745A
BR9809745A BR9809745-8A BR9809745A BR9809745A BR 9809745 A BR9809745 A BR 9809745A BR 9809745 A BR9809745 A BR 9809745A BR 9809745 A BR9809745 A BR 9809745A
Authority
BR
Brazil
Prior art keywords
cefdinir
amine salt
crystalline amine
crystalline
salt
Prior art date
Application number
BR9809745-8A
Other languages
English (en)
Inventor
Hubert Sturm
Siwgfried Wolf
Johannes Ludescher
Original Assignee
Biochemie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochemie Gmbh filed Critical Biochemie Gmbh
Publication of BR9809745A publication Critical patent/BR9809745A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/22—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Patente de Invenção: <B>"SAL CRISTALINO DE AMINA DE CEFDINIR"<D>. Cefdinir na forma de um sal com diciclohexilamina, um processo para sua produção e seu uso na purificação de cefdinir impuro.
BR9809745-8A 1997-04-04 1998-04-02 Sal cristalino de amina de cefdinir BR9809745A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0057097A AT405283B (de) 1997-04-04 1997-04-04 Neues kristallines 7-(z)-(2-(2-aminothiazol-4-yl) -2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4- carbonsäure dicyclohexylammoniumsalz und verfahren zu dessen herstellung
PCT/EP1998/001953 WO1998045299A1 (en) 1997-04-04 1998-04-02 Crystalline amine salt of cefdinir

Publications (1)

Publication Number Publication Date
BR9809745A true BR9809745A (pt) 2000-06-20

Family

ID=3494111

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9809745-8A BR9809745A (pt) 1997-04-04 1998-04-02 Sal cristalino de amina de cefdinir

Country Status (18)

Country Link
US (1) US6350869B1 (pt)
EP (1) EP0973779B1 (pt)
JP (1) JP3421354B2 (pt)
KR (1) KR100442717B1 (pt)
CN (1) CN1139596C (pt)
AT (2) AT405283B (pt)
AU (1) AU731413B2 (pt)
BR (1) BR9809745A (pt)
CA (1) CA2283718A1 (pt)
DE (1) DE69816056T2 (pt)
HU (1) HUP0002987A3 (pt)
ID (1) ID22536A (pt)
IL (1) IL131755A0 (pt)
NO (1) NO994466L (pt)
PL (1) PL335620A1 (pt)
SK (1) SK134399A3 (pt)
TR (1) TR199902406T2 (pt)
WO (1) WO1998045299A1 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080113025A1 (en) * 1998-11-02 2008-05-15 Elan Pharma International Limited Compositions comprising nanoparticulate naproxen and controlled release hydrocodone
KR100451672B1 (ko) * 2001-06-05 2004-10-08 한미약품 주식회사 결정성 세프디니르 산부가염, 이의 제조방법 및 이를이용한 세프디니르의 제조방법
ITMI20020913A0 (it) * 2002-04-29 2002-04-29 Acs Dobfar Spa Nuova forma cristallina del cefdinir
EP1842852A1 (en) 2002-08-13 2007-10-10 Sandoz AG A cefdinir intermediate
ITMI20022076A1 (it) 2002-10-01 2004-04-02 Antibioticos Spa Sali di intermedi del cefdinir.
AU2003276525A1 (en) * 2002-11-15 2004-06-15 Orchid Chemicals And Pharmaceuticals Ltd Novel amorphous hydrate of a cephalosporin antibiotic
ITMI20022724A1 (it) * 2002-12-20 2004-06-21 Antibioticos Spa Sali cristallini del cefdinir.
JPWO2004085443A1 (ja) * 2003-03-24 2006-06-29 ア・チ・エツセ・ドブフアル・エツセ・ピー・アー ７−［２−（２−アミノチアゾール−４−イル）−２−ヒドロキシイミノアセトアミド−３−ビニル−３−セフェム−４−カルボン酸（シン異性体）の新規結晶およびその製造方法
WO2004104010A1 (en) * 2003-05-20 2004-12-02 Ranbaxy Laboratories Limited Crystalline form of cefdinir
US20050137182A1 (en) * 2003-06-02 2005-06-23 Ramesh Dandala Novel crystalline form of cefdinir
US20040242556A1 (en) * 2003-06-02 2004-12-02 Ramesh Dandala Novel crystalline form of cefdinir
US20050059819A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Cefdinir pyridine salt
US20050059818A1 (en) * 2003-09-12 2005-03-17 Duerst Richard W. Polymorph of a pharmaceutical
US20050113355A1 (en) * 2003-09-12 2005-05-26 Duerst Richard W. Cefdinir pyridine salt
US20060142563A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20050209211A1 (en) * 2004-03-16 2005-09-22 Devalina Law Trihemihydrate, anhydrate and novel hydrate forms of Cefdinir
US20060211676A1 (en) * 2004-03-16 2006-09-21 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
US20060142261A1 (en) * 2004-03-16 2006-06-29 Devalina Law Crystalline anhydrous cefdinir and crystalline cefdinir hydrates
WO2005090360A1 (en) * 2004-03-19 2005-09-29 Orchid Chemicals & Pharmaceuticals Limited Novel polymorph of cefdinir
US20060069079A1 (en) * 2004-09-27 2006-03-30 Sever Nancy E Stable amorphous cefdinir
US20050245738A1 (en) * 2004-05-03 2005-11-03 Lupin Ltd Stable bioavailable crystalline form or cefdinir and a process for the preparation thereof
WO2006010978A1 (en) * 2004-06-30 2006-02-02 Wockhardt Limited Cefdinir polymorphic forms, and imidazole salt
EP1765833A2 (en) 2004-07-05 2007-03-28 Orchid Chemicals and Pharmaceuticals Limited News salts in the preparation of cephalosporin antibiotics
WO2006018807A1 (en) * 2004-08-16 2006-02-23 Ranbaxy Laboratories Limited Crystalline forms of cefdinir
ITMI20042231A1 (it) * 2004-11-19 2005-02-19 Antibioticos Spa Cefdinir sale d'ammonio in forma cristallina
MX2007006018A (es) * 2004-11-30 2007-06-07 Astellas Pharma Inc Suspension farmaceutica oral novedosa de cristal de cefdinir.
GB2421024A (en) * 2004-12-07 2006-06-14 Sandoz Ag Cefdinir crystalline form C
WO2006117794A1 (en) * 2005-05-02 2006-11-09 Hetero Drugs Limited A novel crystalline form of cefdinir
US20080287673A1 (en) * 2005-06-15 2008-11-20 Parthasaradhi Reddy Bandk Cefdinir process
CN1903860B (zh) * 2005-07-25 2012-01-18 四川抗菌素工业研究所有限公司 溶媒法制备高纯度头孢他美钠工艺及医药用途
WO2007053722A2 (en) * 2005-10-31 2007-05-10 Teva Pharmaceutical Industries Ltd. Crystalline form of cefdinir cesium salt
US20070128268A1 (en) * 2005-12-07 2007-06-07 Herwig Jennewein Pharmaceutical compositions comprising an antibiotic
CN101481383B (zh) * 2008-12-31 2012-01-11 杭州奥默医药技术有限公司 头孢地尼酸式复盐化合物及制备方法
TR200909784A1 (tr) * 2009-12-25 2011-07-21 Bi̇lgi̇ç Mahmut Yeni sefdinir tuzları
US8614315B2 (en) 2009-12-25 2013-12-24 Mahmut Bilgic Cefdinir and cefixime formulations and uses thereof
CN102010427B (zh) * 2010-11-19 2012-09-12 苏州中联化学制药有限公司 一种头孢地尼的制备方法
CN101974020B (zh) * 2010-11-19 2012-09-12 苏州中联化学制药有限公司 一种头孢地尼的合成方法
CN103012433B (zh) * 2012-12-13 2015-06-24 珠海保税区丽珠合成制药有限公司 头孢地尼晶型b的制备方法
CN111039958B (zh) * 2017-05-31 2022-05-20 郑州大学第一附属医院 头孢地尼的制备方法
CN107286148B (zh) * 2017-06-20 2019-10-15 广州市桐晖通医药科技有限公司 一种头孢地尼的制备方法及其新的中间体化合物
CN111635419B (zh) * 2020-07-13 2022-05-24 广药白云山化学制药(珠海)有限公司 一种头孢地尼精制母液的处理方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5564M (pt) * 1964-03-14 1968-01-02
GB8323034D0 (en) 1983-08-26 1983-09-28 Fujisawo Pharmaceutical Co Ltd 7-substituted-3-vinyl-3-cephem compounds
ZA885709B (en) * 1987-08-19 1989-04-26 Fujisawa Pharmaceutical Co Novel crystalline 7-(2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido)-3-vinyl-3-cephem-4-carboxylic acid(syn isomer)
JP2825655B2 (ja) * 1992-02-05 1998-11-18 バイオケミ・ゲゼルシヤフト・エム・ベー・ハー ３−セフェム−４−カルボン酸誘導体の精製方法
KR960704897A (ko) * 1994-07-22 1996-10-09 에밀리오 마우리 글루타릴 7-아미노세팔로스포란산 유도체 및 이의 제조 방법 (Glutaryl 7-ACA derivatives and processes for obtaining them)
AT403049B (de) * 1995-08-14 1997-10-27 Biochemie Gmbh Abreicherung von 7-adca in 3-vinyl-aca
EP0874853B1 (en) * 1995-12-27 2002-06-05 Hanmi Pharmaceutical Co.,Ltd. Process for preparation of cefdinir
AT404251B (de) * 1996-08-14 1998-10-27 Biochemie Gmbh Neues kristallines salz von cefixim

Also Published As

Publication number Publication date
JP3421354B2 (ja) 2003-06-30
ID22536A (id) 1999-11-04
DE69816056T2 (de) 2004-04-15
HUP0002987A2 (hu) 2001-02-28
IL131755A0 (en) 2001-03-19
US6350869B1 (en) 2002-02-26
CN1139596C (zh) 2004-02-25
JP2000514833A (ja) 2000-11-07
NO994466D0 (no) 1999-09-15
WO1998045299A1 (en) 1998-10-15
AU7428898A (en) 1998-10-30
HUP0002987A3 (en) 2001-04-28
KR100442717B1 (ko) 2004-08-02
PL335620A1 (en) 2000-05-08
KR20010005907A (ko) 2001-01-15
EP0973779A1 (en) 2000-01-26
TR199902406T2 (xx) 2000-02-21
ATA57097A (de) 1998-11-15
SK134399A3 (en) 2000-05-16
DE69816056D1 (de) 2003-08-07
AT405283B (de) 1999-06-25
AU731413B2 (en) 2001-03-29
CN1251590A (zh) 2000-04-26
EP0973779B1 (en) 2003-07-02
NO994466L (no) 1999-09-15
CA2283718A1 (en) 1998-10-15
ATE244249T1 (de) 2003-07-15

Similar Documents

Publication Publication Date Title
BR9809745A (pt) Sal cristalino de amina de cefdinir
BR0112665A (pt) Sais
BR9905852A (pt) Poliuretanos termoplásticos alifáticos, processo para sua preparação e seu emprego
BR9606040A (pt) Processo para a preparação de D,L-mentionina ou do seu sal
FR2777562B1 (fr) Procede de purification d&#39;aminonitriles aliphatiques
PT914119E (pt) Processo para a formacao de formas de dosagem oral solidas de valsartan
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
PT1056722E (pt) Sal de bi-sulfato do inibidor de protease do hiv
BR0111913A (pt) Análogos de gabapentina para distúrbios do sono
BR0307442A (pt) Sais de valsartana
DE69521289D1 (de) Reduktive Aminierung zur selektiven Herstellung von Aminoethylethanolamin
BR9808874B1 (pt) processo para a preparação de um estabilizador com formação de pó reduzida.
BR9712100A (pt) Intermediários e processo para preparar olanzapina.
BR0101230A (pt) Processo para a preparação de11-amino-3-cloro-6,11-diidro-5-5-dioxo-6-metil-dibenzo[c,f][1,2]tiazepina e aplicação para a sìntese detianeptina
BR9810657A (pt) &#34;processo de preparação de um per-hidroisoindol substituìdo&#34;
BR0114379A (pt) Derivados de c-ciclohexilmetilamina substituìdos
BR9916887A (pt) Uso de derivados de pirimidina
DK0630380T3 (da) Fremgangsmåde til rensning af et 3-cephem-4-carboxylsyrederivat
PA8451301A1 (es) Una nueva sal
PT1213294E (pt) Processo de purificacao para a fosfatidilserina
BR9909898A (pt) Processo para purificação de um derivado de cefalosporina
MX9101349A (es) Polimeros que contienen antidegradantes de amina ligados o combinados quimicamente
PT1066276E (pt) Processo para a sintese de inibidores de protease de hiv
PT99598B (pt) Processo para a purificacao de solucoes aquosas de n-metilmorfolina-n-oxido
BR9810481A (pt) Processo para preparação de 1h-indol-3-glioxamidas 4-substituìdas.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A,6A,7A,8A E 9A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1909 DE 07/08/2007.